Pharmaceutical Giant Alembic Hits 52-Week High, Outperforms Sector by 1.71%
Alembic, a leading pharmaceutical company, has reached a 52-week high on July 9th, 2024, gaining attention from investors and market analysts. With a current stock call of 'Hold' by MarketsMojo, Alembic has outperformed the sector by 1.71% and seen a 14.56% rise in the last 3 days. Its impressive 84.14% increase in the past year and positive trend in trading indicate a strong position in the pharma industry. This success can be attributed to its strong product portfolio and focus on research and development, making Alembic a promising stock in the smallcap industry.
Alembic, a leading pharmaceutical company in the smallcap industry, has recently hit a 52-week high on July 9th, 2024. This news has caught the attention of investors and market analysts alike. The stock has been performing well in the past few days, outperforming the sector by 1.71%.
According to MarketsMOJO, a leading stock analysis platform, the current stock call for Alembic is 'Hold'. The stock has been gaining for the last 3 days and has seen a significant rise of 14.56% during this period. On the day of the 52-week high, the stock touched an intraday high of Rs. 136.8, showing a 4.99% increase.
Alembic's performance in the past year has been impressive, with a 84.14% increase compared to the Sensex's 22.74% performance. This further solidifies the company's position as a strong player in the pharma industry.
The stock is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. This is a positive sign for investors and shows the company's consistent growth.
Alembic's success can be attributed to its strong portfolio of products and its focus on research and development. The company has been consistently delivering quality products and has gained a loyal customer base. With its strong performance and growth potential, Alembic is definitely a stock to watch out for in the smallcap industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
